Of note, Wnt5a is able to promote melanoma progression via Fzd5 and the Ca2+ pathway [132], and as canonical Wnt signalling has been shown to be able to inhibit non-canonical signalling, this is a potential mechanism that may help explain how increased canonical Wnt signalling results in reduced melanoma growth [208,209]. The gene discussed is WNT5A; the disease is melanoma.